SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Extra Large Challenges in Steatotic Liver Disease
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
Session Overview
Mark Sulkowski
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Simple Adiposity Measures Identify MASLD in People With HIV: Results From a US Multicenter Cohort (ABSTRACT
599)
Kara Wegermann
Duke University School of Medicine, Durham, NC, USA
Performance of Prediction Scores for Steatotic Liver Disease in Thai PWH on InSTI-Based ART (ABSTRACT
600)
Napon Hiranburana
HIV Netherlands Australia Thailand Research Collaboration, Bangkok, Thailand
Effect of DTG/3TC vs BIC/FTC/TAF on Steatotic Liver Disease: 96-Week Analysis of PASO-DOBLE Trial (ABSTRACT
598)
Juan Macias
University of Sevilla, Sevilla, Spain
Longitudinal Associations of Semaglutide With Liver Fibrosis Score in People With HIV (ABSTRACT
601)
Jimmy Ma
University of Washington, Seattle, WA, USA
Discussion With Audience Questions and Answers
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
